ObesityNCT04046367
Prehabilitation in Bariatric Surgery
A study testing Prehabilitation in people with Obesity and Bariatric Surgery Candidate, run by Hospital Universitario Insular Gran Canaria at 1 site in Spain.
Trial summary
Obesity is a major public health problem in our region and constitutes a priority of the Canary Islands Health Plan. Bariatric surgery is the most effective intervention in the treatment of obesity and its complications. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Obesity, Bariatric Surgery Candidate
- What is being tested?
- Prehabilitation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteSpain
- Study dates
- 22 Aug 2019to 31 Mar 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- People with obesity (type II-IV), on the waiting list for bariatric surgery in the Complejo Hospitalario Universitario Materno-infantil de Las Palmas
Who cannot join
- any factor that, in the opinion of the researchers, limits the ability to monitor the intervention (language barrier, ...).
Trial locations and contacts
1 site in 1 country.
Spain1 site
Complejo Hospitalario Universitario Materno-infantil de Las Palmas
Las Palmas de Gran Canaria, Las Palmas, 35016
Ana M Wägner, M.D., +34 928453431, ana.wagner@ulpgc.es
About this study
Official title: Prehabilitation in Bariatric Surgery: a Randomized Controlled Clinical Trial
Obesity is a major public health problem in our region and constitutes a priority of the Canary Islands Health Plan. Bariatric surgery is the most effective intervention in the treatment of obesity and its complications. However, people with obesity have high surgical risk and long-term outcomes are related to pre-surgical weight loss.
In patients currently on the bariatric surgery waiting list, a randomized controlled trial will be performed in which two group interventions will be compared. One of the interventions (standard), will consist of educational modules in food and exercise, combined with cognitive-behavioral therapy. In the other, a specific training (prehabilitation) will be added to encourage physical activity and the conditioning of inspiratory muscles.
The pre-surgical weight loss (principal outcome) will be compared between groups, as well as the evolution of the complications of obesity, the functional status of the patients, their physical activity, quality of life, immediate complications of surgery and days of admission.
Read the detailed description
Obesity is a major public health problem, responsible for an increased risk of hypertension, obesity, dyslipidemia, type 2 diabetes, cardiovascular disease, some types of cancer, psychiatric diseases and mortality.
Bariatric surgery has proven to be the most effective method for reducing weight and related comorbidities in patients with morbid obesity. However, pre-surgical weight loss reduces postsurgical complications. In addition, weight loss before surgery seems to be the only factor positively associated with post-surgical weight loss, and this effect seems to be more pronounced in patients with BMI> 45 kg / m2.
Pre-operative physical conditioning (prehabilitation) can improve the patient's functional capacity before major surgery. Most studies showing this have been conducted in orthopedic surgery and abdominal cancer surgery. There are very few studies that evaluate prehabilitation in patients undergoing bariatric surgery.
Objective
Comparison of a multidisciplinary group intervention with another one to which specific training focused on increasing physical activity is added, in patients on the surgical waiting list for bariatric surgery in a randomized controlled trial.
Methods
Design Randomized, controlled parallel group, clinical trial.
Intervention Duration: 4-month intervention, with biweekly 2,5-hour group sessions, followed by a monthly reinforcement session of 1h until surgery.
Intervention A: Educational program and cognitive-behavioral intervention (control group)
Intervention B: Educational program and cognitive-behavioral intervention, with specific training aimed at increasing physical activity, functional capacity and conditioning of the respiratory muscles (intervention group).
Study population The recruitment of the participants will be made from the waiting list of bariatric surgery (obesity II-IV), selecting patients with estimated waiting time above 4 months. Patients will be excluded if any reason for inadequate follow-up is identified, according to the investigators criteria.
Ethical aspects The design and execution of this study will be done in accordance with the Declaration of Helsinki and the homogenized European guidelines of good clinical practice. Before their participation, the patients will sign an informed consent form. The protocol has been approved by the local ethics committee
Sample size Based on the size of the waiting list for bariatric surgery, with a mean duration of 17 months, and that the intervention is considered feasible on two groups of 10 people, in parallel, in each branch, (a weekly session of 2h per nutrition nurse, with support from additional professional). Starting with a pilot group of each intervention and taking into account an overlap between them, in 18 months about 60-80 patients could be included in total.
With 80 patients included, without losses, and assuming a standard deviation of weight of 11Kg, and for a bilateral p <0.05 a difference between groups of 7 and 8Kg, with a statistical power of 80 and 90%, respectively. If we assume a standard deviation of 6Kg, as shown by other studies, the detectable difference would be reduced to about 4Kg.
Statistical analysis A descriptive analysis of the baseline situation will be made. The qualitative variables are expressed as a percentage, quantitative, as mean (SD) or median, according to if its distribution is normal or not, respectively. Comparisons will be made between treatment groups, using chi squared for qualitative variables and Student's t or Mann Whitney's U for quantitative variables. The analysis of results will be done by intention to treat analysis. That is, all patients who have baseline data and have been randomized, will be included, regardless of their subsequent attendance to the Program.
- Conditions
- Obesity, Bariatric Surgery Candidate
- Being tested
- Prehabilitation, Control
- Keywords
- nutrition, physical activity, prehabilitation
- Medical subject headings
- Obesity, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PrehabilitationBehavioural
Also called Inspiratory muscle training, physical activity.
Prehabilitation: The intervention of a physiotherapist will be added to the components of the control group. Patients will receive practical instructions on aerobic and resistance physical activity, as well as training of their inspiratory muscles.
ControlBehavioural
Standard group intervention. Educational program and cognitive-behavioral intervention. The patient receives training in nutrition and cognitive-behavioral therapy, as well as standard instructions to increase physical activity.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Educational program and cognitive-behavioral intervention. The patient receives training in nutrition and cognitive-behavioral therapy, with specific training aimed at increasing physical activity, functional capacity and conditioning of the respiratory musculature (prehabilitation by a physiotherapist) Receives: Behavioral: Prehabilitation |
| Control | Active comparator | Educational program and cognitive-behavioral intervention. The patient receives training in nutrition and cognitive-behavioral therapy, as well as standard instructions to increase physical activity. Receives: Behavioral: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight change
Increase (or decrease) in weight between the start of the program and the time of surgery (measured on a calibrated scale, with Maximum increments of 0.1Kg, under the same conditions, without footwear and with light clothing)
Measured: 4-6 months
Secondary outcomes (24)
Body mass index
Calculated as weight (in Kg) divided by the squared height (in meters)
Measured: 4-6 months
Body composition
Percentage of body fat and lean mass estimated by bioimpedance
Measured: 4-6 months
Associated complications-Blood pressure
Systolic and diastolic blood pressure (in sitting position, after 5 minutes of rest, using a manual sphygmomanometer, with a cuff adapted to thebrachial circumference of the patient)
Measured: 4-6 months
Associated complications-lipids
total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides (automatic methods) in mg/dl colorimetric tests)
Measured: 4-6 months
Associated complications-glucose metabolism
HbA1c (HPLC standardized against DCCT-IFCC)
Measured: 4-6 months
Associated complications-treatments
Number of drugs used for associated cardiovascular risk factors
Measured: 4-6 months
Associated complications-liver enzymes
AST, ALT, GGT (automatic methods)
Measured: 4-6 months
Adherence to the intervention
Attendance at the sessions (number of sessions attended) programmed.
Measured: 4-6 months
Physical activity-steps
Registered by pedometers (number of steps/week)
Measured: 4-6 months
Physical activity-self reported
International Physical Activity Program (IPAQ) questionnaire
Measured: 4-6 months
Eating patterns-Adherence to Mediterranean diet
Validated Food questionnaire (simplified questionnaire of 14 questions of adherence to the diet Mediterranean diet of PREDIMED) . Higher scores indicate higher adherence
Measured: 4-6 months
Eating patterns-eating disorders
Standardised questionnaire (bulimia and binge disorders of the EDI -Eating Disorder Inventory)
Measured: 4-6 months
General health status
EQ-5D questionnaire (higher scores indicate better self-perceived health status)
Measured: 4-6 months
Emotional state
Hospital scale of anxiety and depression (HADS)
Measured: 4-6 months
Subjective evaluation of satisfaction, perceived effort and motivation
Development of a specific questionnaire with Likert type scale for the patient to score 1 to 10 each of the 3 items.
Measured: 4-6 months
Functional capacity-walk test
6-minute walk test (TM6): meters completed during the test
Measured: 4-6 months
Functional capacity- grip strength
Grip test: hand grip dynamometer and the grip strength in both hands, indicating the dominant one.
Measured: 4-6 months
Functional capacity-respiratory muscle strength
Maximum inspiratory pressure (PIM) and expiratory pressure (PEM)
Measured: 4-6 months
Functional capacity-plethysmography
Lung volumes, VR (residual volume) and CRF (functional residual capacity) in ml
Measured: 4-6 months
Functional capacity-Spirometry
Forced spirometry: Forced expiratory volume in 1 second (FEV1), Functional Vital Capacity (FVC) in ml. Tiffenau index will be calculated. Mesoespiratory flows
Measured: 4-6 months
Functional capacity-sleep apnea questionnaire
Stop-bang screening questionnaire for sleep-related breathing disorders.
Measured: 4-6 months
Functional capacity-sleep apnea polygraph
Home cardiorespiratory polygraphy for diagnosis of disorder
Measured: 4-6 months
Surgical complications
Early post-surgical complications (<30 days)
Measured: 5-7 months after start of intervention
Surgery-length of admission
Post-surgical length of stay (stratified by surgical technique).
Measured: 5-7 months after start of intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2019
- Study start22 Aug 2019 (estimated)
- Primary completion31 Dec 2020 (estimated)
- Study completion31 Mar 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized, controlled clinical trial, which will compare two group interventions in patients on the waiting list for bariatric surgery. Duration: 4-month intervention, with biweekly 2-hour group sessions c / un, followed by a monthly reinforcement session of 1h until surgical intervention. Intervention A: Educational program and cognitive-behavioral intervention (group control) Intervention B: Educational program and cognitive-behavioral intervention, with specific training aimed at increasing physical activity, capacity functional and conditioning of the respiratory musculature (group of intervention).
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital Universitario Insular Gran Canaria
- Sponsor type
- University, hospital or other
- Collaborators
- Fundación MAPFRE Guanarteme
- Responsible party
- Principal investigator, Rosa María Sánchez Hernández, Hospital Universitario Insular Gran Canaria
- Investigators
- Ana M Wägner, MD, PhD, Principal investigator, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04046367
- Sponsor's protocol ID
- 2018-170
- Status last verified
- Aug 2019
- First submitted
- 14 Jun 2019
- Last updated
- 6 Aug 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Anonymized data will be shared upon request
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prehabilitation in Bariatric Surgery: a Randomized Controlled Clinical Trial
- ClinicalTrials.gov ID
- NCT04046367
- Acronym / sponsor ID
- 2018-170
- Conditions
- Obesity, Bariatric Surgery Candidate
- Keywords
- nutrition, physical activity, prehabilitation
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Hospital Universitario Insular Gran CanariaUniversity, hospital or other
- Collaborators
- Fundación MAPFRE Guanarteme
- Study start
- 22 Aug 2019 (estimated)
- Primary completion
- 31 Dec 2020 (estimated)
- Study completion
- 31 Mar 2021 (estimated)
- First posted
- 6 Aug 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Obesity is a major public health problem in our region and constitutes a priority of the Canary Islands Health Plan. Bariatric surgery is the most effective intervention in the treatment of obesity and its complications. However, people with obesity have high surgical risk and long-term outcomes are related to pre-surgical weight loss.
In patients currently on the bariatric surgery waiting list, a randomized controlled trial will be performed in which two group interventions will be compared. One of the interventions (standard), will consist of educational modules in food and exercise, combined with cognitive-behavioral therapy. In the other, a specific training (prehabilitation) will be added to encourage physical activity and the conditioning of inspiratory muscles.
The pre-surgical weight loss (principal outcome) will be compared between groups, as well as the evolution of the complications of obesity, the functional status of the patients, their physical activity, quality of life, immediate complications of surgery and days of admission.
Detailed description
Obesity is a major public health problem, responsible for an increased risk of hypertension, obesity, dyslipidemia, type 2 diabetes, cardiovascular disease, some types of cancer, psychiatric diseases and mortality.
Bariatric surgery has proven to be the most effective method for reducing weight and related comorbidities in patients with morbid obesity. However, pre-surgical weight loss reduces postsurgical complications. In addition, weight loss before surgery seems to be the only factor positively associated with post-surgical weight loss, and this effect seems to be more pronounced in patients with BMI> 45 kg / m2.
Pre-operative physical conditioning (prehabilitation) can improve the patient's functional capacity before major surgery. Most studies showing this have been conducted in orthopedic surgery and abdominal cancer surgery. There are very few studies that evaluate prehabilitation in patients undergoing bariatric surgery.
Objective
Comparison of a multidisciplinary group intervention with another one to which specific training focused on increasing physical activity is added, in patients on the surgical waiting list for bariatric surgery in a randomized controlled trial.
Methods
Design Randomized, controlled parallel group, clinical trial.
Intervention Duration: 4-month intervention, with biweekly 2,5-hour group sessions, followed by a monthly reinforcement session of 1h until surgery.
Intervention A: Educational program and cognitive-behavioral intervention (control group)
Intervention B: Educational program and cognitive-behavioral intervention, with specific training aimed at increasing physical activity, functional capacity and conditioning of the respiratory muscles (intervention group).
Study population The recruitment of the participants will be made from the waiting list of bariatric surgery (obesity II-IV), selecting patients with estimated waiting time above 4 months. Patients will be excluded if any reason for inadequate follow-up is identified, according to the investigators criteria.
Ethical aspects The design and execution of this study will be done in accordance with the Declaration of Helsinki and the homogenized European guidelines of good clinical practice. Before their participation, the patients will sign an informed consent form. The protocol has been approved by the local ethics committee
Sample size Based on the size of the waiting list for bariatric surgery, with a mean duration of 17 months, and that the intervention is considered feasible on two groups of 10 people, in parallel, in each branch, (a weekly session of 2h per nutrition nurse, with support from additional professional). Starting with a pilot group of each intervention and taking into account an overlap between them, in 18 months about 60-80 patients could be included in total.
With 80 patients included, without losses, and assuming a standard deviation of weight of 11Kg, and for a bilateral p <0.05 a difference between groups of 7 and 8Kg, with a statistical power of 80 and 90%, respectively. If we assume a standard deviation of 6Kg, as shown by other studies, the detectable difference would be reduced to about 4Kg.
Statistical analysis A descriptive analysis of the baseline situation will be made. The qualitative variables are expressed as a percentage, quantitative, as mean (SD) or median, according to if its distribution is normal or not, respectively. Comparisons will be made between treatment groups, using chi squared for qualitative variables and Student's t or Mann Whitney's U for quantitative variables. The analysis of results will be done by intention to treat analysis. That is, all patients who have baseline data and have been randomized, will be included, regardless of their subsequent attendance to the Program.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized, controlled clinical trial, which will compare two group interventions in patients on the waiting list for bariatric surgery. Duration: 4-month intervention, with biweekly 2-hour group sessions c / un, followed by a monthly reinforcement session of 1h until surgical intervention. Intervention A: Educational program and cognitive-behavioral intervention (group control) Intervention B: Educational program and cognitive-behavioral intervention, with specific training aimed at increasing physical activity, capacity functional and conditioning of the respiratory musculature (group of intervention).
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: PrehabilitationEducational program and cognitive-behavioral intervention. The patient receives training in nutrition and cognitive-behavioral therapy, with specific training aimed at increasing physical activity, functional capacity and conditioning of the respiratory musculature (prehabilitation by a physiotherapist) |
| Control | Active comparator | Behavioral: ControlEducational program and cognitive-behavioral intervention. The patient receives training in nutrition and cognitive-behavioral therapy, as well as standard instructions to increase physical activity. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- People with obesity (type II-IV), on the waiting list for bariatric surgery in the Complejo Hospitalario Universitario Materno-infantil de Las Palmas
Key exclusion criteria (1 listed)
- any factor that, in the opinion of the researchers, limits the ability to monitor the intervention (language barrier, ...).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PrehabilitationAlso: Inspiratory muscle training, physical activity.Prehabilitation: The intervention of a physiotherapist will be added to the components of the control group. Patients will receive practical instructions on aerobic and resistance physical activity, as well as training of their inspiratory muscles. | Behavioural | Intervention |
| ControlStandard group intervention. Educational program and cognitive-behavioral intervention. The patient receives training in nutrition and cognitive-behavioral therapy, as well as standard instructions to increase physical activity. | Behavioural | Control |
Primary outcome
Weight change
Time frame: 4-6 months
Increase (or decrease) in weight between the start of the program and the time of surgery (measured on a calibrated scale, with Maximum increments of 0.1Kg, under the same conditions, without footwear and with light clothing)
24 secondary outcomes
Body mass index
Time frame: 4-6 months
Body composition
Time frame: 4-6 months
Associated complications-Blood pressure
Time frame: 4-6 months
Associated complications-lipids
Time frame: 4-6 months
Associated complications-glucose metabolism
Time frame: 4-6 months
Associated complications-treatments
Time frame: 4-6 months
Associated complications-liver enzymes
Time frame: 4-6 months
Adherence to the intervention
Time frame: 4-6 months
Physical activity-steps
Time frame: 4-6 months
Physical activity-self reported
Time frame: 4-6 months
Eating patterns-Adherence to Mediterranean diet
Time frame: 4-6 months
Eating patterns-eating disorders
Time frame: 4-6 months
General health status
Time frame: 4-6 months
Emotional state
Time frame: 4-6 months
Subjective evaluation of satisfaction, perceived effort and motivation
Time frame: 4-6 months
Functional capacity-walk test
Time frame: 4-6 months
Functional capacity- grip strength
Time frame: 4-6 months
Functional capacity-respiratory muscle strength
Time frame: 4-6 months
Functional capacity-plethysmography
Time frame: 4-6 months
Functional capacity-Spirometry
Time frame: 4-6 months
Functional capacity-sleep apnea questionnaire
Time frame: 4-6 months
Functional capacity-sleep apnea polygraph
Time frame: 4-6 months
Surgical complications
Time frame: 5-7 months after start of intervention
Surgery-length of admission
Time frame: 5-7 months after start of intervention
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2019.
- Individual participant dataSharing planned: Yes. Anonymized data will be shared upon request
Related trials for Obesity
Active, not recruiting
Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Bariatric Surgery Candidate, Obesity
RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Not yet recruitingPhase 1
A Study of Safety of SUN-0864 and How it is Processed by and Affects the Body in Healthy Adults and Healthy Adults Who Are Overweight or Obese.
Healthy Participants
Not yet recruiting
Evaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With Obesity
Obese Adults
Not yet recruiting
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ana M Wägner, MD, PhD principal investigator
Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Prehabilitation in people with Obesity and Bariatric Surgery Candidate, run by Hospital Universitario Insular Gran Canaria at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ana M Wägner, MD,PhD (+34 928441617, awagfah@gobiernodecanarias.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight change (time frame: 4-6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2019.